| 1 | [Dexamethasone sodium phosphate] | [1] Dexamethasone Dexamethasone (Dexamethasone sodium phosphate) | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
(Dexamethasone sodium phosphate),
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 65 65 💬
|
| 2 | Bortezomib+Dexamethasone/Bortezomib+Dexamethasone+Daratumumab/single Daratumumab (Dexamethasone sodium phosphate) | [3] Bortezomib Bortezomib, Daratumumab, Dexamethasone (Dexamethasone sodium phosphate) | [5] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
(Dexamethasone sodium phosphate),
Bortezomib
,
Dexamethasone phosphate
,
Daratumumab
💬
| [3] CD38 CD38, NR3C1, PSMB5 💬
| [15] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Calcium signaling pathway, Hematopoietic cell lineage, Huntington disease, Neuroactive ligand-receptor interaction, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Salivary secretion, Spinocerebellar ataxia 💬 | [1] 28 28 💬
|
| 3 | Bortezomib/dexamethasone (Dexamethasone sodium phosphate) | [2] Bortezomib Bortezomib, Dexamethasone (Dexamethasone sodium phosphate) | [4] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
(Dexamethasone sodium phosphate),
Bortezomib
,
Dexamethasone phosphate
💬
| [2] NR3C1 NR3C1, PSMB5 💬
| [9] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | [1] 283 283 💬
|
| 4 | Bortezomib/Dexamethasone (BD), Followed By Autologous STC & Maintenance Bortezomib/Dexamethasone (Dexamethasone sodium phosphate) | [2] Bortezomib Bortezomib, Dexamethasone (Dexamethasone sodium phosphate) | [4] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
(Dexamethasone sodium phosphate),
Bortezomib
,
Dexamethasone phosphate
💬
| [2] NR3C1 NR3C1, PSMB5 💬
| [9] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | [1] 28 28 💬
|
| 5 | Bupivacaine/epinephrine/dexamethasone (Dexamethasone sodium phosphate) | [3] Bupivacaine Bupivacaine, Dexamethasone (Dexamethasone sodium phosphate), Epinephrine | [8] Epinephrine
Epinephrine
,
Dexamethasone
,
Dexamethasone sodium phosphate
(Dexamethasone sodium phosphate),
Epinephrine hydrochloride
,
Bupivacaine hydrochloride
,
Epinephrine bitartrate
,
Bupivacaine
,
Dexamethasone phosphate
💬
| [16] ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, NR3C1, SCN1A, SCN2A, SCN3A, SCN5A, SCN8A, SCN9A 💬
| [20] AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Cadherin signaling, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Hormone signaling, IgSF CAM signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 96 96 💬
|
| 6 | CARFILZOMIB, CYCLOPHOSPHAMIDE, DEXAMETHASONE (Dexamethasone sodium phosphate) | [3] Carfilzomib Carfilzomib, Cyclophosphamide, Dexamethasone (Dexamethasone sodium phosphate) | [6] Cyclophosphamide
Cyclophosphamide
,
Dexamethasone
,
Dexamethasone sodium phosphate
(Dexamethasone sodium phosphate),
Cyclophosphamide
,
Dexamethasone phosphate
,
Carfilzomib
💬
| [2] NR3C1 NR3C1, PSMB5 💬
| [9] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | [1] 16 16 💬
|
| 7 | Combination of Protein A Immunoadsorption, Rituximab, Dexamethasone plus Azathioprine (Dexamethasone sodium phosphate) | [3] Azathioprine Azathioprine, Dexamethasone (Dexamethasone sodium phosphate), Rituximab | [6] Azathioprine
Azathioprine
,
Dexamethasone
,
Dexamethasone sodium phosphate
(Dexamethasone sodium phosphate),
Rituximab
,
Azathioprine sodium
,
Dexamethasone phosphate
💬
| [2] MS4A1 MS4A1, NR3C1 💬
| [2] Hematopoietic cell lineage Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬 | [1] 35 35 💬
|
| 8 | Control intervention (no dexamethasone) (Dexamethasone sodium phosphate) | [1] Dexamethasone Dexamethasone (Dexamethasone sodium phosphate) | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
(Dexamethasone sodium phosphate),
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 46 46 💬
|
| 9 | Conventional Glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone) (Dexamethasone sodium phosphate) | [7] Acetate Acetate, Cortisone, Cortisone acetate, Dexamethasone (Dexamethasone sodium phosphate), Hydrocortisone, Prednisolone, Prednisone | [8] Hydrocortisone
Hydrocortisone
,
Dexamethasone
,
Prednisolone
,
Prednisone
,
Cortisone acetate
,
Dexamethasone sodium phosphate
(Dexamethasone sodium phosphate),
Cortisone
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 81 81 💬
|
| 10 | Cyclophosphamide, bortezomib, and Dexamethasone (CyBorD) regimen (Dexamethasone sodium phosphate) | [3] Bortezomib Bortezomib, Cyclophosphamide, Dexamethasone (Dexamethasone sodium phosphate) | [6] Cyclophosphamide
Cyclophosphamide
,
Dexamethasone
,
Dexamethasone sodium phosphate
(Dexamethasone sodium phosphate),
Bortezomib
,
Cyclophosphamide
,
Dexamethasone phosphate
💬
| [2] NR3C1 NR3C1, PSMB5 💬
| [9] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | [1] 28 28 💬
|
| 11 | Dexamethasone (Dexamethasone sodium phosphate) | [1] Dexamethasone Dexamethasone (Dexamethasone sodium phosphate) | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
(Dexamethasone sodium phosphate),
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [29] 13 13, 14, 16, 19, 28, 35, 46, 53, 63, 64, 65, 70, 71, 74, 75, 81, 84, 90, 96, 97, 162, 222, 223, 235, 257, 283, 296, 299, 331 💬
|
| 12 | Dexamethasone (1 cycle) (Dexamethasone sodium phosphate) | [1] Dexamethasone Dexamethasone (Dexamethasone sodium phosphate) | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
(Dexamethasone sodium phosphate),
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 63 63 💬
|
| 13 | Dexamethasone (4 cycles) (Dexamethasone sodium phosphate) | [1] Dexamethasone Dexamethasone (Dexamethasone sodium phosphate) | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
(Dexamethasone sodium phosphate),
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 63 63 💬
|
| 14 | Dexamethasone (50mg 1dd6, 3 consecutive days/month) (Dexamethasone sodium phosphate) | [1] Dexamethasone Dexamethasone (Dexamethasone sodium phosphate) | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
(Dexamethasone sodium phosphate),
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 35 35 💬
|
| 15 | Dexamethasone (IV) (Dexamethasone sodium phosphate) | [1] Dexamethasone Dexamethasone (Dexamethasone sodium phosphate) | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
(Dexamethasone sodium phosphate),
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 96 96, 97 💬
|
| 16 | Dexamethasone (or equivalent) (Dexamethasone sodium phosphate) | [1] Dexamethasone Dexamethasone (Dexamethasone sodium phosphate) | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
(Dexamethasone sodium phosphate),
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 257 257 💬
|
| 17 | Dexamethasone 0,1 mg Tablets (Dexamethasone sodium phosphate) | [1] Dexamethasone Dexamethasone (Dexamethasone sodium phosphate) | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
(Dexamethasone sodium phosphate),
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 81 81 💬
|
| 18 | Dexamethasone 0,5mg (Dexamethasone sodium phosphate) | [1] Dexamethasone Dexamethasone (Dexamethasone sodium phosphate) | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
(Dexamethasone sodium phosphate),
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 84 84 💬
|
| 19 | Dexamethasone 0.5mg Tablet (Dexamethasone sodium phosphate) | [1] Dexamethasone Dexamethasone (Dexamethasone sodium phosphate) | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
(Dexamethasone sodium phosphate),
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 81 81 💬
|
| 20 | Dexamethasone 0.5mg/5ml solution (Dexamethasone sodium phosphate) | [1] Dexamethasone Dexamethasone (Dexamethasone sodium phosphate) | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
(Dexamethasone sodium phosphate),
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 35 35, 162 💬
|
| 21 | Dexamethasone 0.5mg/5ml solution in Mucolox™ (Dexamethasone sodium phosphate) | [1] Dexamethasone Dexamethasone (Dexamethasone sodium phosphate) | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
(Dexamethasone sodium phosphate),
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 35 35, 162 💬
|
| 22 | Dexamethasone 1,5 mg Tablets (Dexamethasone sodium phosphate) | [1] Dexamethasone Dexamethasone (Dexamethasone sodium phosphate) | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
(Dexamethasone sodium phosphate),
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 81 81 💬
|
| 23 | Dexamethasone 2mg Tablets (Dexamethasone sodium phosphate) | [1] Dexamethasone Dexamethasone (Dexamethasone sodium phosphate) | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
(Dexamethasone sodium phosphate),
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 81 81 💬
|
| 24 | Dexamethasone 4 mg JENAPHARM (Dexamethasone sodium phosphate) | [1] Dexamethasone Dexamethasone (Dexamethasone sodium phosphate) | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
(Dexamethasone sodium phosphate),
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 28 28 💬
|
| 25 | Dexamethasone 4 Mg/mL Injectable Solution (Dexamethasone sodium phosphate) | [1] Dexamethasone Dexamethasone (Dexamethasone sodium phosphate) | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
(Dexamethasone sodium phosphate),
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 70 70 💬
|
| 26 | Dexamethasone Abcur (Dexamethasone sodium phosphate) | [1] Dexamethasone Dexamethasone (Dexamethasone sodium phosphate) | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
(Dexamethasone sodium phosphate),
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 63 63 💬
|
| 27 | DEXAMETHASONE ACETATE (Dexamethasone sodium phosphate) | [3] Acetate Acetate, Dexamethasone (Dexamethasone sodium phosphate), Dexamethasone acetate | [5] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
(Dexamethasone sodium phosphate),
Dexamethasone acetate
,
Dexamethasone 21-acetate
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 63 63 💬
|
| 28 | Dexamethasone and Rituximab (Dexamethasone sodium phosphate) | [2] Dexamethasone Dexamethasone (Dexamethasone sodium phosphate), Rituximab | [4] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
(Dexamethasone sodium phosphate),
Rituximab
,
Dexamethasone phosphate
💬
| [2] MS4A1 MS4A1, NR3C1 💬
| [2] Hematopoietic cell lineage Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬 | [1] 63 63 💬
|
| 29 | Dexamethasone Azathioprine Pulse therapy (Dexamethasone sodium phosphate) | [2] Azathioprine Azathioprine, Dexamethasone (Dexamethasone sodium phosphate) | [5] Azathioprine
Azathioprine
,
Dexamethasone
,
Dexamethasone sodium phosphate
(Dexamethasone sodium phosphate),
Azathioprine sodium
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 35 35 💬
|
| 30 | Dexamethasone Combined with romiplostim N01 (Dexamethasone sodium phosphate) | [2] Dexamethasone Dexamethasone (Dexamethasone sodium phosphate), Romiplostim | [4] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
(Dexamethasone sodium phosphate),
Dexamethasone phosphate
,
Romiplostim
💬
| [2] MPL MPL, NR3C1 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction 💬 | [1] 63 63 💬
|
| 31 | Dexamethasone Cyclophosphamide Pulse therapy (Dexamethasone sodium phosphate) | [2] Cyclophosphamide Cyclophosphamide, Dexamethasone (Dexamethasone sodium phosphate) | [5] Cyclophosphamide
Cyclophosphamide
,
Dexamethasone
,
Dexamethasone sodium phosphate
(Dexamethasone sodium phosphate),
Cyclophosphamide
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 35 35 💬
|
| 32 | Dexamethasone given orally (Dexamethasone sodium phosphate) | [1] Dexamethasone Dexamethasone (Dexamethasone sodium phosphate) | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
(Dexamethasone sodium phosphate),
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 13 13 💬
|
| 33 | Dexamethasone injection (Dexamethasone sodium phosphate) | [1] Dexamethasone Dexamethasone (Dexamethasone sodium phosphate) | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
(Dexamethasone sodium phosphate),
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 90 90 💬
|
| 34 | Dexamethasone Krka (Dexamethasone sodium phosphate) | [1] Dexamethasone Dexamethasone (Dexamethasone sodium phosphate) | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
(Dexamethasone sodium phosphate),
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 28 28 💬
|
| 35 | Dexamethasone monotherapy (Dexamethasone sodium phosphate) | [1] Dexamethasone Dexamethasone (Dexamethasone sodium phosphate) | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
(Dexamethasone sodium phosphate),
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 63 63 💬
|
| 36 | Dexamethasone oral (Dexamethasone sodium phosphate) | [1] Dexamethasone Dexamethasone (Dexamethasone sodium phosphate) | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
(Dexamethasone sodium phosphate),
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 63 63 💬
|
| 37 | Dexamethasone oral tablet 8mg (Dexamethasone Krka tablets(8mg), Warsaw, Poland). (Dexamethasone sodium phosphate) | [1] Dexamethasone Dexamethasone (Dexamethasone sodium phosphate) | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
(Dexamethasone sodium phosphate),
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 235 235 💬
|
| 38 | Dexamethasone Oral, 10 mg (Dexamethasone sodium phosphate) | [1] Dexamethasone Dexamethasone (Dexamethasone sodium phosphate) | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
(Dexamethasone sodium phosphate),
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 28 28 💬
|
| 39 | Dexamethasone Oral, 20 mg (Dexamethasone sodium phosphate) | [1] Dexamethasone Dexamethasone (Dexamethasone sodium phosphate) | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
(Dexamethasone sodium phosphate),
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 28 28 💬
|
| 40 | Dexamethasone palmitate (Dexamethasone sodium phosphate) | [2] Dexamethasone Dexamethasone (Dexamethasone sodium phosphate), Dexamethasone palmitate | [4] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
(Dexamethasone sodium phosphate),
Dexamethasone palmitate
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 63 63 💬
|
| 41 | Dexamethasone Parotid Irrigation (Dexamethasone sodium phosphate) | [1] Dexamethasone Dexamethasone (Dexamethasone sodium phosphate) | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
(Dexamethasone sodium phosphate),
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 53 53 💬
|
| 42 | DEXAMETHASONE SODIUM PHOSPHATE | [1] Dexamethasone Dexamethasone (Dexamethasone sodium phosphate) | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
(Dexamethasone sodium phosphate),
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [3] 65 65, 70, 96 💬
|
| 43 | Dexamethasone sodium phosphate (soluzione 25mg/ml) | [1] Dexamethasone Dexamethasone (Dexamethasone sodium phosphate) | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
(Dexamethasone sodium phosphate),
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 65 65 💬
|
| 44 | Dexamethasone sodium phosphate 250 mg/ 10 ml | [1] Dexamethasone Dexamethasone (Dexamethasone sodium phosphate) | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
(Dexamethasone sodium phosphate),
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 96 96 💬
|
| 45 | Dexamethasone sodium phosphate 250 mg/10 ml solution | [1] Dexamethasone Dexamethasone (Dexamethasone sodium phosphate) | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
(Dexamethasone sodium phosphate),
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 299 299 💬
|
| 46 | DEXAMETHASONE SODIUM PHOSPHATE PH. EUR. | [1] Dexamethasone Dexamethasone (Dexamethasone sodium phosphate) | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
(Dexamethasone sodium phosphate),
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 65 65 💬
|
| 47 | DEXAMETHASONE SODIUM SULFATE (Dexamethasone sodium phosphate) | [2] Dexamethasone Dexamethasone (Dexamethasone sodium phosphate), Sodium sulfate | [5] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
(Dexamethasone sodium phosphate),
Anhydous sodium sulfate
,
Sodium sulfate
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 28 28 💬
|
| 48 | Dexamethasone soduim phosphate (Dexamethasone sodium phosphate) | [1] Dexamethasone Dexamethasone (Dexamethasone sodium phosphate) | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
(Dexamethasone sodium phosphate),
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 13 13 💬
|
| 49 | Dexamethasone USP Micronized (Dexamethasone sodium phosphate) | [1] Dexamethasone Dexamethasone (Dexamethasone sodium phosphate) | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
(Dexamethasone sodium phosphate),
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 63 63 💬
|
| 50 | Dexamethasone, 40 mg (Dexamethasone sodium phosphate) | [1] Dexamethasone Dexamethasone (Dexamethasone sodium phosphate) | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
(Dexamethasone sodium phosphate),
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 28 28 💬
|
| 51 | Dexamethasone, procarbazine (Dexamethasone sodium phosphate) | [2] Dexamethasone Dexamethasone (Dexamethasone sodium phosphate), Procarbazine | [5] Dexamethasone
Dexamethasone
,
Procarbazine hydrochloride
,
Dexamethasone sodium phosphate
(Dexamethasone sodium phosphate),
Dexamethasone phosphate
,
Procarbazine
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 65 65 💬
|
| 52 | Diagnostic Test: Dexamethasone suppression test (Dexamethasone sodium phosphate) | [1] Dexamethasone Dexamethasone (Dexamethasone sodium phosphate) | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
(Dexamethasone sodium phosphate),
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 75 75 💬
|
| 53 | Diagnostic Test: Dexamethasone test (Dexamethasone sodium phosphate) | [1] Dexamethasone Dexamethasone (Dexamethasone sodium phosphate) | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
(Dexamethasone sodium phosphate),
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 75 75 💬
|
| 54 | Eltrombopag and dexamethasone (Dexamethasone sodium phosphate) | [2] Dexamethasone Dexamethasone (Dexamethasone sodium phosphate), Eltrombopag | [5] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
(Dexamethasone sodium phosphate),
Eltrombopag olamine
,
Dexamethasone phosphate
,
Eltrombopag choline
💬
| [2] MPL MPL, NR3C1 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction 💬 | [1] 63 63 💬
|
| 55 | Epidural steroid (dexamethasone) injection (Dexamethasone sodium phosphate) | [1] Dexamethasone Dexamethasone (Dexamethasone sodium phosphate) | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
(Dexamethasone sodium phosphate),
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 70 70 💬
|
| 56 | High dose dexamethasone (Dexamethasone sodium phosphate) | [1] Dexamethasone Dexamethasone (Dexamethasone sodium phosphate) | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
(Dexamethasone sodium phosphate),
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 63 63 💬
|
| 57 | High dose Dexamethasone pulses (Dexamethasone sodium phosphate) | [1] Dexamethasone Dexamethasone (Dexamethasone sodium phosphate) | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
(Dexamethasone sodium phosphate),
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 63 63 💬
|
| 58 | High-dose Dexamethasone (Dexamethasone sodium phosphate) | [1] Dexamethasone Dexamethasone (Dexamethasone sodium phosphate) | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
(Dexamethasone sodium phosphate),
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 63 63 💬
|
| 59 | High-Dose Dexamethasone Combined (Dexamethasone sodium phosphate) | [1] Dexamethasone Dexamethasone (Dexamethasone sodium phosphate) | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
(Dexamethasone sodium phosphate),
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 63 63 💬
|
| 60 | High-Dose Dexamethasone Combined with Orelabrutinib (Dexamethasone sodium phosphate) | [2] Dexamethasone Dexamethasone (Dexamethasone sodium phosphate), Orelabrutinib | [4] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
(Dexamethasone sodium phosphate),
Dexamethasone phosphate
,
Orelabrutinib
💬
| [2] BTK BTK, NR3C1 💬
| [8] B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Neuroactive ligand-receptor interaction, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 | [1] 63 63 💬
|
| 61 | Intraarticular dexamethasone (Dexamethasone sodium phosphate) | [1] Dexamethasone Dexamethasone (Dexamethasone sodium phosphate) | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
(Dexamethasone sodium phosphate),
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 46 46 💬
|
| 62 | Intravenous Dexamethasone 1 mg (Dexamethasone sodium phosphate) | [1] Dexamethasone Dexamethasone (Dexamethasone sodium phosphate) | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
(Dexamethasone sodium phosphate),
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 46 46 💬
|
| 63 | Lenalidomide and dexamethasone (Dexamethasone sodium phosphate) | [2] Dexamethasone Dexamethasone (Dexamethasone sodium phosphate), Lenalidomide | [4] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
(Dexamethasone sodium phosphate),
Lenalidomide
,
Dexamethasone phosphate
💬
| [2] NR3C1 NR3C1, TNF 💬
| [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 16 16 💬
|
| 64 | Lenalidomide+Dexamethasone (Dexamethasone sodium phosphate) | [2] Dexamethasone Dexamethasone (Dexamethasone sodium phosphate), Lenalidomide | [4] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
(Dexamethasone sodium phosphate),
Lenalidomide
,
Dexamethasone phosphate
💬
| [2] NR3C1 NR3C1, TNF 💬
| [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 16 16 💬
|
| 65 | Lenalidomide, Dexamethasone (Dexamethasone sodium phosphate) | [2] Dexamethasone Dexamethasone (Dexamethasone sodium phosphate), Lenalidomide | [4] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
(Dexamethasone sodium phosphate),
Lenalidomide
,
Dexamethasone phosphate
💬
| [2] NR3C1 NR3C1, TNF 💬
| [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 16 16 💬
|
| 66 | Lenalidomide, Dexamethasone and Cyclophosphamide (Dexamethasone sodium phosphate) | [3] Cyclophosphamide Cyclophosphamide, Dexamethasone (Dexamethasone sodium phosphate), Lenalidomide | [6] Cyclophosphamide
Cyclophosphamide
,
Dexamethasone
,
Dexamethasone sodium phosphate
(Dexamethasone sodium phosphate),
Lenalidomide
,
Cyclophosphamide
,
Dexamethasone phosphate
💬
| [2] NR3C1 NR3C1, TNF 💬
| [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 28 28 💬
|
| 67 | Live Combined Bacillus Subtilis and Enterococcus Faecium Enteric-coated Capsules combined with Bortezomib+Dexamethasone/Bortezomib+Dexamethasone+Daratumumab/single Daratumumab (Dexamethasone sodium phosphate) | [5] Bacillus subtilis Bacillus subtilis, Bortezomib, Daratumumab, Dexamethasone (Dexamethasone sodium phosphate), Enterococcus faecium | [5] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
(Dexamethasone sodium phosphate),
Bortezomib
,
Dexamethasone phosphate
,
Daratumumab
💬
| [3] CD38 CD38, NR3C1, PSMB5 💬
| [15] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Calcium signaling pathway, Hematopoietic cell lineage, Huntington disease, Neuroactive ligand-receptor interaction, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Salivary secretion, Spinocerebellar ataxia 💬 | [1] 28 28 💬
|
| 68 | Melphalan, thalidomide and dexamethasone (Dexamethasone sodium phosphate) | [3] Dexamethasone Dexamethasone (Dexamethasone sodium phosphate), Melphalan, Thalidomide | [6] Dexamethasone
Dexamethasone
,
Melphalan
,
Thalidomide
,
Dexamethasone sodium phosphate
(Dexamethasone sodium phosphate),
Dexamethasone phosphate
,
Melphalan hydrochloride
💬
| [2] NR3C1 NR3C1, TNF 💬
| [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 28 28 💬
|
| 69 | MMF and Dexamethasone (Dexamethasone sodium phosphate) | [1] Dexamethasone Dexamethasone (Dexamethasone sodium phosphate) | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
(Dexamethasone sodium phosphate),
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 222 222 💬
|
| 70 | Peri-neural Dexamethasone 1 mg (Dexamethasone sodium phosphate) | [1] Dexamethasone Dexamethasone (Dexamethasone sodium phosphate) | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
(Dexamethasone sodium phosphate),
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 46 46 💬
|
| 71 | Pomalidomide and Dexamethasone (Dexamethasone sodium phosphate) | [2] Dexamethasone Dexamethasone (Dexamethasone sodium phosphate), Pomalidomide | [4] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
(Dexamethasone sodium phosphate),
Dexamethasone phosphate
,
Pomalidomide
💬
| [3] IL6 IL6, NR3C1, TNF 💬
| [79] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 28 28 💬
|
| 72 | Rituximab and dexamethasone (Dexamethasone sodium phosphate) | [2] Dexamethasone Dexamethasone (Dexamethasone sodium phosphate), Rituximab | [4] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
(Dexamethasone sodium phosphate),
Rituximab
,
Dexamethasone phosphate
💬
| [2] MS4A1 MS4A1, NR3C1 💬
| [2] Hematopoietic cell lineage Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬 | [1] 63 63 💬
|
| 73 | Romiplostim N01 combined with dexamethasone (Dexamethasone sodium phosphate) | [2] Dexamethasone Dexamethasone (Dexamethasone sodium phosphate), Romiplostim | [4] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
(Dexamethasone sodium phosphate),
Dexamethasone phosphate
,
Romiplostim
💬
| [2] MPL MPL, NR3C1 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction 💬 | [1] 63 63 💬
|
| 74 | Romiplostim plus dexamethasone (Dexamethasone sodium phosphate) | [2] Dexamethasone Dexamethasone (Dexamethasone sodium phosphate), Romiplostim | [4] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
(Dexamethasone sodium phosphate),
Dexamethasone phosphate
,
Romiplostim
💬
| [2] MPL MPL, NR3C1 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction 💬 | [1] 63 63 💬
|
| 75 | SoC: cyclophosphamide, bortezomib, and Dexamethasone (CyBorD) (Dexamethasone sodium phosphate) | [3] Bortezomib Bortezomib, Cyclophosphamide, Dexamethasone (Dexamethasone sodium phosphate) | [6] Cyclophosphamide
Cyclophosphamide
,
Dexamethasone
,
Dexamethasone sodium phosphate
(Dexamethasone sodium phosphate),
Bortezomib
,
Cyclophosphamide
,
Dexamethasone phosphate
💬
| [2] NR3C1 NR3C1, PSMB5 💬
| [9] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | [1] 28 28 💬
|
| 76 | Venetoclax MTD with Dexamethasone (Dexamethasone sodium phosphate) | [2] Dexamethasone Dexamethasone (Dexamethasone sodium phosphate), Venetoclax | [4] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
(Dexamethasone sodium phosphate),
Dexamethasone phosphate
,
Venetoclax
💬
| [2] BCL2 BCL2, NR3C1 💬
| [41] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Amyotrophic lateral sclerosis, Apoptosis, Apoptosis - multiple species, Autophagy - animal, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Colorectal cancer, Epstein-Barr virus infection, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, Gastric cancer, HIF-1 signaling pathway, Hedgehog signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Human immunodeficiency virus 1 infection, JAK-STAT signaling pathway, Lipid and atherosclerosis, Measles, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Neuroactive ligand-receptor interaction, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Prostate cancer, Protein processing in endoplasmic reticulum, Salmonella infection, Shigellosis, Small cell lung cancer, Sphingolipid signaling pathway, Toxoplasmosis, Tuberculosis, p53 signaling pathway 💬 | [1] 28 28 💬
|